Local antiviral activity of the drug «Thymogen®», nasal dosed spray, against SARS-CoV-2 coronavirus <i>in vitro</i> by I. A. Leneva, V. S. Smirnov, T. A. Kudryavtseva, E. B. Fayzuloev, A. V. Gracheva, N. P. Kartashova, V. A. Zaplutanov, S. V. Petlenko

Get full text

Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2 by B. S. Cherepovich, A. M. Kudryashova, N. P. Kartashova, A. V. Gracheva, V. A. Manuilov, I. A. Leneva, O. V. Borisova, O. A. Svitich

Get full text

Possibilities of suppressing the cytopathogenic effect of SARS-CoV-2 coronavirus according to the results of the antiviral activity of Cytovir®-3 <i>in vitro</i> study by V. S. Smirnov, I. A. Leneva, T. A. Kudryavtseva, E. B. Fayzuloev, V. A. Zaplutanov, S. V. Petlenko, N. P. Kartashova, A. V. Gracheva, E. R. Korchevaya

Get full text

Antiviral Activity of Cytovir^®-3 Against Human Rotavirus Infection Agent <i>in vitro</i> by E. B. Faizuloev, I. A. Leneva, V. S. Smirnov, D. I. Smirnova, A. V. Gracheva, E. R. Korchevaya, D. M. Khokhlova, T. A. Kudryavtseva, S. V. Petlenko, V. A. Zaplutanov

Get full text